Emerging Therapeutic Discovery Against Escherichia coli Infection by Rational Inhibition of Fatty Acid Responsive Transcription Factor: Theoretical Molecular Investigations of Some Metabolites as Inhibitors of Fatty Acid Metabolism Protein

Authors

  • Tomy Muringayil Joseph Polymer Research Division, CSIR-Indian Institute of Chemical Technology, Hyderabad-500007, Telangana, India
  • Debarshi Kar Mahapatra Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur 440037, Maharashtra, India

DOI:

https://doi.org/10.37591/rrjocb.v7i3.496

Keywords:

Chromene, FadR, Furan, Furan-2-yl, Macrolactin, Docking

Abstract

 

For the discovery of effective agent for overcoming resistance against Escherichia coli (E. coli) bacteria by modulating Fatty Acid Metabolism Protein (FadR)—a Fatty Acid Responsive Transcription Factor. The present study involved discovery of some metabolites of furan, furan-2-yl, macrolactin, and chromene scaffold via in silico structure-based drug design (SBDD) technique by utilizing the Maestro 9.1 software. The study will provide clues, motivate, and throw light on imperative aspects for the globally working medicinal chemists in the rational designing of anti-infective drugs in the near future.

 

Keywords: Chromene, FadR, furan, furan-2-yl, macrolactin

Cite this Article

Joseph TM, Mahapatra DK. Emerging Therapeutic Discovery against Escherichia coli Infection by Rational Inhibition of Fatty Acid Responsive Transcription Factor: Theoretical Molecular Investigations of some Metabolites as Inhibitors of Fatty Acid Metabolism Protein. Research & Reviews: Journal of Computational Biology. 2018; 7(3): 1–7p

Author Biographies

  • Tomy Muringayil Joseph, Polymer Research Division, CSIR-Indian Institute of Chemical Technology, Hyderabad-500007, Telangana, India

    Polymer Research Division,CSIR-Indian Institute of Chemical Technology, Hyderabad-500007, Telangana, India

  • Debarshi Kar Mahapatra, Department of Pharmaceutical Chemistry, Dadasaheb Balpande College of Pharmacy, Nagpur 440037, Maharashtra, India

    Assistant Professor,

    Department of Pharmaceutical Chemistry,

    Dadasaheb Balpande College of Pharmacy,

    Nagpur 440037, Maharashtra, India

References

Allocati N, Masulli M, Alexeyev MF, Di Ilio C. Escherichia coli in Europe: an overview. Int J Environ Res Public Health. 2013;10(12):6235-54p.

Mahapatra DK, Bharti SK. Handbook of Research on Medicinal Chemistry. 1st ed. Apple Academic Press, New Jersey, 2017.

Fujita Y, Matsuoka H, Hirooka K. Regulation of fatty acid metabolism in bacteria. Mol Microbiol. 2007;66(4):829-39p.

Van Aalten DM, DiRusso CC, Knudsen J, Wierenga RK. Crystal structure of FadR, a fatty acid‐responsive transcription factor with a novel acyl coenzyme A‐binding fold. EMBO J. 2000;19(19):5167-77p.

DiRusso CC, Heimert TL, Metzger AK. Characterization of FadR, a global transcriptional regulator of fatty acid metabolism in Escherichia coli. Interaction with the fadB promoter is prevented by long chain fatty acyl coenzyme A. J Biol Chem. 1992;267(12):8685-91p.

Mahapatra DK, Das D, Shivhare RS. Substituted thiazole linked murrayanine-Schiff’s base derivatives as potential anti-breast cancer candidates: Future EGFR Kinase inhibitors. Int J Pharm Sci Drug Res. 2017;9(3):139-44p.

Chhajed SS, Chaskar S, Kshirsagar SK, Haldar AGM, Mahapatra DK. Rational design and synthesis of some PPAR-γ agonists: substituted benzylideneamino-benzylidene-thiazolidine-2,4-diones. Comp Biol Chem. 2017;67:260-5p.

Mahapatra DK, Das D, Shivhare RS, Borkar SS. Murrayanine-hydantoin and -thiohydantoin analogs as promising anti-convulsant agents: Synthesis, Characterization and Molecular Docking Studies. MOJ Bioorg Org Chem. 2018;2(2):47-51p.

Downloads

Published

2018-11-14

Issue

Vol. 7 No. 3 (2018)

Section

Research Article

License

Declaration and Copyright Transfer Form

(to be completed by authors)

I/ We, the undersigned author(s) of the submitted manuscript, hereby declare, that the above manuscript which is submitted for publication in the STM Journals(s), is not published already in part or whole (except in the form of abstract) in any journal or magazine for private or public circulation, and, is not under consideration of publication elsewhere.

  • I/We will not withdraw the manuscript after 1 week of submission as I have read the Author Guidelines and will adhere to the guidelines.
  • I/We Author(s ) have niether given nor will give this manuscript elsewhere for publishing after submitting in STM Journal(s).
  • I/ We have read the original version of the manuscript and am/ are responsible for the thought contents embodied in it. The work dealt in the manuscript is my/ our own, and my/ our individual contribution to this work is significant enough to qualify for authorship.
  •  I/We also agree to the authorship of the article in the following order:

Author’s name                                    

 

1. ________________

2. ________________

3. ________________

4. ________________

 

We  Author(s) tick this box and would request you to consider it as our signature as we agree to the terms of this Copyright Notice, which will apply to this submission if and when it is published by this journal.